RTD® iPSC & GMP Cell Banks

A comprehensive solution encompassing products, technologies, and services for gene-edited GMP iPSC banks, spanning the entire process. 

The Ready-to-Differentiate® Solution

Pluristyx Ready-to-Differentiate® (RTD®) format iPSCs eliminate the need for time-intensive and expensive pre-differentiation expansion.  Stem cells in our proprietary RTD® format are frozen at high density and can be turned into product, immediately out of thaw. This cell bank format aides in the manufacturing process for cellular products. RTD® iPSC cell banks are subject to our quality control testing to ensure cell viability out of thaw. This format is available in both research and GMP Cell banking services.

By eliminating the need to generate enough starting material for differentiation, we simplify your manufacturing process. We believe our proprietary format is crucial for the process development of any cell therapy. Pluristyx RTD® cells are fully characterized, genetically stable, and can be generated from any iPSC starting material. This formate is available in either research working cell banks or clinical-grade format. Pluristyx can also provide GMP and research grade banks in regular format.

1–100 Million Cells per Vial

Ready-to-Differentiate® (RTD®) Vials are prepared at high density, removing the need for front end expansion allowing you to efficiently differentiate cells for fast assessment.

Stringent Quality Control

iPSC quality control testing is paramount for cell bank generationTesting is completed to confirm the performance of the cells recovered from the RTD® vials. 

Controlled Cryopreservation

Cryopreserved RTD®
high-density vials can be thawed and used immediately in a laboratory procedure and/or when initiating a cell differentiation protocol.

We Simplify the Stem Cell Therapy
Development Process

Gene Editing

Explore More about our iPSC Solutions

Human Pluripotent Stem Cells

Pluristyx’s off-the-shelf human induced pluripotent stem cells are ready for immediate evaluation in both unmodified and genetically edited versions. hiPSCs are generated from regulatory-compliant donors and can be accessed for a low upfront fee to help select an appropriate line for your downstream cell-based application.
Shop Now

panCELLa Platform

Developing the next generation of stem cell therapies is slow, difficult, and expensive. To help you convert your concept into a clinical reality, Pluristyx has the expertise needed to take on the most challenging parts of your stem cell process: including CMC support, gene editing, process and analytical development services, along with cell line development.
Learn More

Contact us to learn more about RTD® and GMP Cell Banks

Shopping Cart
Scroll to Top